1314891-22-9 Usage
Uses
Used in Pharmaceutical Development:
N-[2-Methyl-2-(2-phenyloxazol-4-yl)propyl]-3-[5-(trifluoroMethyl)-1,2,4-oxadiazol-3-yl]benzaMide is used as a candidate for the development of new drugs due to its unique structure and potential to interact with specific biological targets, which may be beneficial in treating certain medical conditions.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, N-[2-Methyl-2-(2-phenyloxazol-4-yl)propyl]-3-[5-(trifluoroMethyl)-1,2,4-oxadiazol-3-yl]benzaMide is utilized for research purposes to explore its properties and understand how it may be applied in the treatment of various diseases. Further studies are necessary to determine its full potential and effects on biological systems.
Check Digit Verification of cas no
The CAS Registry Mumber 1314891-22-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,4,8,9 and 1 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1314891-22:
(9*1)+(8*3)+(7*1)+(6*4)+(5*8)+(4*9)+(3*1)+(2*2)+(1*2)=149
149 % 10 = 9
So 1314891-22-9 is a valid CAS Registry Number.
1314891-22-9Relevant articles and documents
METHODS OF USE OF A CLASS llA HDAC INHIBITOR
-
, (2017/08/01)
Novel uses of selective class Ila HDAC inhibitors are described.
COMPOUNDS AND METHODS for the inhibition of HDAC
-
Paragraph 0157-0158; 0411-0412; 0686-0687, (2015/11/24)
Disclosed are compounds having the formula: wherein X1, X2, X3, R1, R2, R3, R4, Y, A, Z, L and n are as defined herein, and methods of making and using the same.
